Clinical ResearchBiomarker: Editorial CommentWill SCUBE1 Solve the Ischemia Marker Deficit?⁎
Biomarker: Editorial Comment
Under an Elsevier user license
open archive
Cited by (0)
Dr. Peacock is on the Scientific Advisory Board of Abbott, Beckman-Coulter, Biosite, Inovise, Inverness, Ortho Clinical Diagnostics, and The Medicines Co. He has received research grants from Abbott, Biosite, Brahms, CHF Solutions, Heartscape, Inovise, Inverness, PDL, and The Medicines Co. He has been on the Speakers' Bureau for Abbott, Biosite, Ortho Clinical Diagnostics, PDL, and Scios and he also has ownership interest in Vital Sensors.
- ⁎
Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
Copyright © 2008 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.